Literature DB >> 17853269

Obsessive-compulsive disorder followed by psychotic episode in long-term ecstasy misuse.

Carlo Marchesi1, Matteo Tonna, Carlo Maggini.   

Abstract

AIM: We report the case of two young subjects who developed an obsessive-compulsive disorder (OCD) during a heavy use of ecstasy. After several months of discontinuation of the drug, major depression with psychotic features developed in one subject and a psychotic disorder in the other individual. No mental disorder preceded the use of ecstasy in any subject.
FINDINGS: A familial and personality vulnerability for mental disorder was revealed in one subject, but not in the other, and all physical, laboratory and cerebral NMR evaluations showed normal results in both patients. Remission of OCD and depressive episode or psychotic disorder was achieved after treatment with a serotoninergic medication associated with an antipsychotic.
CONCLUSIONS: The heavy long-term use of ecstasy may induce an alteration in the brain balance between serotonin and dopamine, which might constitute a pathophysiological mechanism underlying the onset of obsessive-compulsive, depressive and psychotic symptoms. The heavy use of ecstasy probably interacted with a vulnerability to psychiatric disorder in one subject, whereas we cannot exclude that an "ecstasy disorder" ex novo affected the other individual.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 17853269     DOI: 10.1080/15622970701459828

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  4 in total

1.  Obsessive-compulsive symptom severity in schizophrenia: a Janus Bifrons effect on functioning.

Authors:  Matteo Tonna; Rebecca Ottoni; Francesca Paglia; Paolo Ossola; Chiara De Panfilis; Carlo Marchesi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-06-06       Impact factor: 5.270

2.  Plasma oxytocin changes and anti-obsessive response during serotonin reuptake inhibitor treatment: a placebo controlled study.

Authors:  Mats B Humble; Kerstin Uvnäs-Moberg; Ingemar Engström; Susanne Bejerot
Journal:  BMC Psychiatry       Date:  2013-12-23       Impact factor: 3.630

3.  Paradoxical effects of low dose MDMA on latent inhibition in the rat.

Authors:  A J D Nelson; K E Thur; C A Marsden; H J Cassaday
Journal:  Neuropharmacology       Date:  2012-11-29       Impact factor: 5.250

4.  Symptomatological features of patients with and without Ecstasy use during their first psychotic episode.

Authors:  Fabio Rugani; Silvia Bacciardi; Luca Rovai; Matteo Pacini; Angelo Giovanni Icro Maremmani; Joseph Deltito; Liliana Dell'osso; Icro Maremmani
Journal:  Int J Environ Res Public Health       Date:  2012-06-27       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.